BRPI0510775A - biomarcadores para a previsão da reação ao tratamento com clozapina - Google Patents
biomarcadores para a previsão da reação ao tratamento com clozapinaInfo
- Publication number
- BRPI0510775A BRPI0510775A BRPI0510775-0A BRPI0510775A BRPI0510775A BR PI0510775 A BRPI0510775 A BR PI0510775A BR PI0510775 A BRPI0510775 A BR PI0510775A BR PI0510775 A BRPI0510775 A BR PI0510775A
- Authority
- BR
- Brazil
- Prior art keywords
- biomarkers
- treatment
- clozapine
- reaction
- slc6a3
- Prior art date
Links
- QZUDBNBUXVUHMW-UHFFFAOYSA-N clozapine Chemical compound C1CN(C)CCN1C1=NC2=CC(Cl)=CC=C2NC2=CC=CC=C12 QZUDBNBUXVUHMW-UHFFFAOYSA-N 0.000 title abstract 3
- 229960004170 clozapine Drugs 0.000 title abstract 3
- 239000000090 biomarker Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 abstract 4
- 108010044266 Dopamine Plasma Membrane Transport Proteins Proteins 0.000 abstract 2
- 101150085000 SLC6A3 gene Proteins 0.000 abstract 2
- 102000005029 SLC6A3 Human genes 0.000 abstract 1
- 230000002596 correlated effect Effects 0.000 abstract 1
- 238000001514 detection method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/156—Polymorphic or mutational markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/172—Haplotypes
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Health & Medical Sciences (AREA)
- Wood Science & Technology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pathology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57713104P | 2004-06-04 | 2004-06-04 | |
| PCT/EP2005/006002 WO2005118848A1 (en) | 2004-06-04 | 2005-06-03 | Biomarkers for the prediction of responsiveness to clozapine treatment |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BRPI0510775A true BRPI0510775A (pt) | 2007-11-20 |
Family
ID=34970966
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0510775-0A BRPI0510775A (pt) | 2004-06-04 | 2005-06-03 | biomarcadores para a previsão da reação ao tratamento com clozapina |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US20090281090A1 (enExample) |
| EP (1) | EP1756314A1 (enExample) |
| JP (1) | JP2008505060A (enExample) |
| CN (1) | CN1973051A (enExample) |
| AU (1) | AU2005250142B2 (enExample) |
| BR (1) | BRPI0510775A (enExample) |
| CA (1) | CA2568729A1 (enExample) |
| MX (1) | MXPA06014127A (enExample) |
| RU (1) | RU2006146207A (enExample) |
| WO (1) | WO2005118848A1 (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9012143B2 (en) * | 2007-04-30 | 2015-04-21 | The Ohio State University Research Foundation | Polymorphisms in genes affecting ace-related disorders and uses thereof |
| US7932042B1 (en) | 2010-10-13 | 2011-04-26 | Suregene, Llc | Methods and compositions for the treatment of psychotic disorders through the identification of the olanzapine poor response predictor genetic signature |
| WO2012167281A2 (en) * | 2011-06-02 | 2012-12-06 | Gareth Davies | Clinical application utilizing genetic data for effective medication management |
| EP2883052B8 (en) | 2012-08-10 | 2019-03-13 | Istituto Superiore di Sanità | Biomarkers |
| CN112195230B (zh) * | 2020-09-17 | 2022-08-23 | 青岛大学附属医院 | 一种用于氯氮平个体化用药指导的基因检测试剂、试剂盒、检测方法及应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2381525A (en) * | 2001-11-01 | 2003-05-07 | Tcs Cellworks Ltd | Regulating gene expression |
| WO2003070082A2 (en) * | 2002-02-21 | 2003-08-28 | Idgene Pharmaceuticals Ltd. | Association of snps in the comt locus and neighboring loci with schizophrenia, bipolar disorder, breast cancer and colorectal cancer |
| WO2003101377A2 (en) * | 2002-06-03 | 2003-12-11 | Idgene Pharmaceuticals Ltd. | Association of snps in the dgcr2 locus and neighboring loci with schizophrenia |
| JP2006518206A (ja) * | 2003-02-21 | 2006-08-10 | ノバルティス アクチエンゲゼルシャフト | 処置中の自殺傾向を予測するための方法 |
-
2005
- 2005-06-03 WO PCT/EP2005/006002 patent/WO2005118848A1/en not_active Ceased
- 2005-06-03 AU AU2005250142A patent/AU2005250142B2/en not_active Ceased
- 2005-06-03 US US11/571,001 patent/US20090281090A1/en not_active Abandoned
- 2005-06-03 CN CNA2005800178554A patent/CN1973051A/zh active Pending
- 2005-06-03 RU RU2006146207/13A patent/RU2006146207A/ru not_active Application Discontinuation
- 2005-06-03 JP JP2007513872A patent/JP2008505060A/ja active Pending
- 2005-06-03 EP EP05754261A patent/EP1756314A1/en not_active Withdrawn
- 2005-06-03 CA CA002568729A patent/CA2568729A1/en not_active Abandoned
- 2005-06-03 MX MXPA06014127A patent/MXPA06014127A/es not_active Application Discontinuation
- 2005-06-03 BR BRPI0510775-0A patent/BRPI0510775A/pt not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| WO2005118848A1 (en) | 2005-12-15 |
| EP1756314A1 (en) | 2007-02-28 |
| MXPA06014127A (es) | 2007-01-31 |
| US20090281090A1 (en) | 2009-11-12 |
| AU2005250142A1 (en) | 2005-12-15 |
| RU2006146207A (ru) | 2008-07-20 |
| CN1973051A (zh) | 2007-05-30 |
| AU2005250142B2 (en) | 2008-08-21 |
| CA2568729A1 (en) | 2005-12-15 |
| JP2008505060A (ja) | 2008-02-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Urdaneta et al. | Purification of cross-linked RNA-protein complexes by phenol-toluol extraction | |
| Krakau et al. | PureCLIP: capturing target-specific protein–RNA interaction footprints from single-nucleotide CLIP-seq data | |
| CN107002289B (zh) | 用于定量评价dna-蛋白质复合物密度的组合物和方法 | |
| RU2009139295A (ru) | Биомаркеры и биомаркерные признаки почечной сохранности, обладающие предсказательной силой, для использования в мониторинге состояния почек | |
| EP2021534A4 (en) | ESTIMATE AND REDUCE THE RISK OF GRAFT VERSUS HOST REACTION | |
| WO2006128192A3 (en) | Use of free circulating dna for diagnosis, prognosis, and treatment of cancer | |
| IN2014DN04226A (enExample) | ||
| BRPI0715126B8 (pt) | métodos para avaliação do risco de intervenções cardíacas e usos à base de gdf-15 | |
| DE602006020544D1 (de) | Apolipoprotein-a-ii-isoform als biomarker für prostatakrebs | |
| JP2009515553A5 (enExample) | ||
| WO2008060483A3 (en) | Protein-protein interaction biosensors and methods of use thereof | |
| WO2008048508A3 (en) | Prognostic biomarkers in patients with ovarian cancer | |
| WO2008011620A3 (en) | Methods and nucleic acids for analyses of cellular proliferative disorders | |
| Liu et al. | Phylogenetic and ecophysiological novelty of subsurface mercury methylators in mangrove sediments | |
| EP2943794B1 (en) | Biomarker panel for predicting recurrecne of prostate cancer | |
| MXPA05008793A (es) | Metodos para la prediccion de posibilidad de suicidio durante el tratamiento. | |
| US20190024184A1 (en) | Distinguishing metastatic-lethal prostate cancer from indolent prostate cancer using methylation status of epigenetic markers | |
| NZ593392A (en) | Biomarker for detecting bladder cancer | |
| WO2007070560A3 (en) | Method for identification and monitoring of epigenetic modifications | |
| WO2007030949A3 (en) | Methods of diagnosing ovarian cancer and kits therefor | |
| WO2009125936A3 (ko) | 다낭성 난소 증후군 진단을 위한 분석방법 및 키트 | |
| Lazaryan et al. | Evolving concepts in prognostic scoring of chronic GvHD | |
| WO2008049225A8 (en) | Methods for diagnosing osteoarthritis | |
| WO2009090269A8 (en) | Markers and diagnostic methods for metastasis | |
| Sun et al. | Identification of candidate biomarkers for hepatocellular carcinoma through pre-cancerous expression analysis in an HBx transgenic mouse |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application fees: application dismissed [chapter 8.6 patent gazette] |
Free format text: REFERENTE AS 6A E 7A ANUIDADES. |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2158 DE 15/05/2012. |